临床研究
算法的影响,一个新的“上门服务”对术后疼痛管理及其副作用在住院的长度:Two-Centre前瞻性随机试验
表3
人口结构、人体测量学和临床特点的病人(
)包含在克拉斯诺达尔大学医院的研究。
|
| 变量 |
ESS () |
VNRS () |
控制() |
价值 |
|
| 年龄:平均数±标准差 |
55.2±14.7 |
55.1±15.6 |
56±14.9 |
|
| 体重指数:平均数±标准差 |
28±17 |
27.8±5.9 |
25.1±4.5 |
|
| 性别 |
|
| 男:(%) |
69例(38.2%) |
69例(36.4%) |
49 (48%) |
|
| 女:(%) |
112例(61.8%) |
121例(63.6%) |
53 (51.9%) |
| ASA分类:(%) |
|
| 亚撒我 |
8 (4.4%) |
11 (5.7%) |
26 (25.5%) |
|
| 亚撒二世 |
99例(54.6%) |
100例(52.6%) |
53 (51.9%) |
| ASA三世 |
72例(39.7%) |
78例(41%) |
22 (21.6%) |
| ASA四世 |
2 (1.1%) |
2 (1%) |
1 (0.9%) |
| 手术的类型:(%) |
|
| 腹部 |
115例(63.5%) |
125例(65.7%) |
61例(59.8%) |
|
| 内分泌 |
29 (16%) |
18 (9.4%) |
5 (4.9%) |
| 妇科 |
19 (10.4%) |
9 (4.7%) |
12 (11.7%) |
| 泌尿外科 |
13 (7.1%) |
18 (9.4%) |
16 (15.6%) |
| 血管 |
5 (2.7%) |
20 (10.5%) |
8 (7.8%) |
| 类型的麻醉:(%) |
|
| Sevo +芬太尼 |
100例(55.2%) |
103例(54.2%) |
38 (37.2%) |
|
| Sevo +芬太尼+ EDA |
77例(42.5%) |
68例(35.7%) |
45 (44.1%) |
| SA±EDA |
/ 6 7例(3.8%)(3.3%) |
15 (7.8%)/ 7 (3.6%) |
14 (13.7%)/ 4 (3.9%) |
| TIVA |
3 (1.6%) |
2 (1%) |
5 (4.9%) |
|
|
;广场的分析。Sevo:七氟醚;EDA:硬膜外麻醉;山:脊髓麻醉。TIVA:总静脉麻醉。
|
